← brief for 2026-11-12 · Slowing decline
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
Key takeaways
This trial is starting to test a new heart monitor. It uses AI to check potassium levels in people with kidney disease. There are no results yet.
Who did this work
Run by Peking University First Hospital.
Sites: Peking University First Hospital · The First Affiliated Hospital of Guangxi Medical University · Hubei Provincial Hospital of TCM
Source
Trial · ClinicalTrials.gov, CKD recruiting · 2026-11-12
https://clinicaltrials.gov/study/NCT06901960